Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor alpha joining 61 (TRAJ61) is a gene segment within the human T cell receptor alpha locus. It encodes a joining (J) region used in DNA recombination to generate the diversity of the alpha chain of T cell receptors. TRAJ61 is annotated as non-functional, meaning it does not encode a functional J segment and does not contribute to mature T cell receptor proteins. T cell receptors are fundamental components of the adaptive immune response, recognizing antigen-derived peptides presented by MHC molecules on antigen-presenting cells. However, as a non-functional J-region segment, TRAJ61 has no direct role in receptor function or therapeutic applications. Key point: TRAJ61 is a non-functional gene segment within the T cell receptor gene cluster, not a standalone drug target or functional receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor alpha joining 61 (non-functional) (TRAJ61).